The Pelotonia Institute for Immuno-Oncology

The next frontier in cancer research

The Pelotonia Institute for Immuno-Oncology was established in 2019 with an initial pledge of $102,265,000 from the Pelotonia community.

Led by inaugural Director Dr. Zihai Li, this research initiative focuses on harnessing the body’s immune system to fight cancer at all levels. The PIIO has achieved the following milestones:

  • • Launched 99 human clinical trials
  • • Obtained $32 million in annual funding from new grants
  • • Assisted in immunotherapeutic studies relating to the COVID-19 pandemic
  • • Published more than 500 peer-reviewed articles

Led by inaugural Director Dr. Zihai Li, this research initiative focuses on harnessing the body’s immune system to fight cancer at all levels. The PIIO has achieved the following milestones:

More about The Institute

Immunotherapy 101

A Q&A on what immunotherapy is and its benefits.

ReadGo

One Goal Podcast on Immuno-oncology

Dr. Zihai Li and Dr. David Carbone discuss immuno-oncology and its importance.

ListenGo

Strategic Plan

The future of The Pelotonia Institute for Immuno-Oncology.

DiscoverGo

News

The latest news coming from The Pelotonia Institute for Immuno-Oncology.

ReadGo

Annual Report

A comprehensive look at the PIIO's progress in accomplishing its goals in talent, research, honors and resources.

Download and ShareGo

The Institute was made possible by you, the Pelotonia community. Let's continue making BIG things happen!

GoGive to Pelotonia
100% of participant-raised funds go to innovative cancer research.

450 W. Broad Street, Columbus, OH | 614.221.6100

© 2022 Pelotonia. All rights reserved.

Major Funding Partners